Avelumab alone or in combination with pegylated liposomal doxorubicin versus pegylated liposomal doxorubicin alone in platinum-resistant or refractory epithelial ovarian cancer: Primary and biomarker analysis of the phase III JAVELIN Ovarian 200 trial - Pujade-Lauraine, E; Fujiwara, K; Ledermann, J A (Gynecol Oncol, 2019)